期刊文献+

角膜胶原交联联合药物治疗感染性角膜疾病的临床研究 被引量:12

Corneal collagen crosslinking in the treatment of infectious keratitis
原文传递
导出
摘要 目的 探讨角膜胶原交联联合药物治疗感染性角膜疾病的可行性以及临床疗效.方法 回顾性研究.收集自2011年11月至2012年1月于厦门大学附属厦门眼科中心住院治疗的感染性角膜病患者19例(19只眼),在联合用药无效或效果不佳的情况下进行角膜胶原交联,术后观察指标:主观症状、最佳矫正视力、角膜溃疡愈合情况以及共聚焦显微镜检查.结果 术后1周,15例患者病情好转,3例病情稳定,1例病情恶化;术后1个月,13例患者角膜溃疡愈合,5例病情明显好转,1例穿孔;术后2个月,17例患者角膜溃疡愈合,2例角膜溃疡穿孔,所有17例角膜溃疡愈合患者术后平均随访6个月,无复发.手术前、后最佳矫正视力为眼前手动或眼前指数分别为11只眼和4只眼,0.02 ~0.08分别为5和3只眼,0.1 ~0.2者分别为3和5只眼,术后为0.3 ~0.5者为2只眼,0.5以上者4只眼.与术前相比,术后15只眼裸眼视力提高,4只眼不变.结论 角膜胶原交联联合药物治疗可能是治疗感染性角膜疾病的一个重要补充. Objective To investigate the feasibility and clinical efficacy of corneal collagen crosslinking (CXL) for the treatment of infectious keratitis.Methods Noncomparative interventional case series.19 patients with infectious keratitis admitted to our hospital between November 2011 and January 2012 were recruited into this study,CXL was performed when medications combined proved poor therapeuticeffects.Postoperatively,the graft status,graft clarity,the visual prognosis and postoperative complications were recorded.Results In 15 cases,there was improvement in symptoms one week after operation.3 cases remained stable,while 1 case reported deteriorated function at the same time.One month after operation,Corneal melting was arrested and complete epithelialization was achieved in 13 cases,5 cases experienced significant improvement and 1 patient experienced corneal ulcer perforation.2 month after surgery,patients with healed corneal ulcer increased to 17cases,and 2 cases experienced corneal ulcer perforation.Those 17 cases with healed corneal ulcer were followed up for 6 months,15 cases had significant improvement in best-corrected visual acuity,2 cases had no significant change,and no relapse was observed in those 17 cases.Conclusion Our experience based on the above and other cases suggest that CXL could be an effective tool in battling difficult cases of infectious keratitis.This treatment could present many advantages but will need further investigation both by in vitro and in vivo studies.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2013年第10期890-895,共6页 Chinese Journal of Ophthalmology
基金 福建省医学创新基金(2012-CXB-30) 厦门市科技计划项目(3502Z20124037,3502Z20114009) 厦门市国家/省科技配套基金(2011S0589)
关键词 角膜溃疡 胶原 交联试剂 光化学疗法 治疗结果 Corneal ulcer Collagen Cross-linking reagents Photochemotherapy Treatment outcome
  • 相关文献

参考文献23

  • 1Kolli S,Aslanides IM.Safety and efficacy of collagen crosslinking for the treatment of keratoconus.Expert Opin Drug Saf,2010,9:949-957.
  • 2Goldich Y,Marcovich AL,Barkana Y,et al.Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus.Cornea,2010,29:409-411.
  • 3潘红卫,陈建苏.紫外光核黄素交联治疗圆锥角膜的研究进展[J].眼科研究,2008,26(5):397-400. 被引量:14
  • 4Schnitzler E,Sp(o)rl E,Seiler T.Irradiation of cornea with cultraviolet light and riboflavin administration as a new treatment for erosive corneal processes,preliminary results in four patients.Klin Monbl Augenheilkd,2000,217:190-193.
  • 5Xie L,Zhai H,Zhao J,et al.Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province,China.Am J Ophthalmol,2008,146:260-265.
  • 6谢立信.真菌性角膜炎[J].中华眼科杂志,2003,39(10):638-640. 被引量:130
  • 7王殿强,董燕玲,赵靖,臧新杰,谢立信.改良角膜溃疡清创术联合抗真菌药物治疗真菌性角膜溃疡[J].眼科,2010,19(3):166-170. 被引量:20
  • 8史伟云,李素霞.结膜瓣遮盖术在难治性角膜溃疡治疗中的临床价值[J].中华眼科杂志,2007,43(4):293-296. 被引量:59
  • 9Carrasco MA,Genesoni G.Treatment of severe fungal keratitis with subconjunctival amphotericin B.Cornea,2011,30:608-611.
  • 10Martins SA,Combs JC,Noguera G,et al.Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates:a potential new treatment for infectious keratitis.Invest Ophthalmol Vis Sci,2008,49:3402-3408.

二级参考文献56

共引文献212

同被引文献114

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部